We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Stakeholders Push for Same Name for Biosimilars in Letter to Hamburg
Stakeholders Push for Same Name for Biosimilars in Letter to Hamburg
June 19, 2012
Proponents of biosimilars carrying the same name as their reference biologic got a boost from a coalition of consumer advocates who penned a letter to FDA Commissioner Margaret Hamburg urging same-name use.